OptimizeRx Corporation provided earnings guidance for the year 2024. For the year, the company expects revenue to be at least $110 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.07 USD | -0.45% | -5.46% | -22.57% |
Jun. 05 | Transcript : OptimizeRx Corporation - Shareholder/Analyst Call | |
May. 14 | Transcript : OptimizeRx Corporation, Q1 2024 Earnings Call, May 14, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.57% | 203M | |
+27.66% | 443B | |
+31.95% | 276B | |
+11.84% | 145B | |
+8.59% | 93.11B | |
+26.22% | 90.17B | |
+63.96% | 61.13B | |
+13.10% | 46.32B | |
+23.05% | 35.73B | |
-12.60% | 31.13B |
- Stock Market
- Equities
- OPRX Stock
- News OptimizeRx Corporation
- OptimizeRx Corporation Provides Earnings Guidance for the Year 2024